Properties (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
legal case
|
| gptkbp:caseTypes |
appeal
2007-1130 |
| gptkbp:citedBy |
numerous patent cases
|
| gptkbp:court |
gptkb:United_States_Court_of_Appeals_for_the_Federal_Circuit
affirmed lower court's ruling |
| gptkbp:decidedBy |
October 30, 2008
|
| gptkbp:field |
business
law technology |
| gptkbp:gameFeatures |
Bernard Bilski
|
| gptkbp:impact |
software patents
|
| gptkbp:influencedBy |
Supreme_Court_decisions
|
| gptkbp:involves |
business methods
|
| gptkbp:judges |
gptkb:Judge_Newman
Federal_Circuit_review |
| gptkbp:keyIssues |
abstract ideas
|
| gptkbp:legalStatus |
intellectual property
machine-or-transformation test business methods are not patentable narrowed scope of patentable inventions not all inventions are patentable patent application rejected Bilski_v._Kappos,_561_U.S._593_(2010) |
| gptkbp:notableEvent |
35 U.S.C. § 101
|
| gptkbp:outcome |
reaffirmed the machine-or-transformation test
|
| gptkbp:politicalParty |
gptkb:Judge_Rader
|
| gptkbp:precedent |
patent eligibility
|
| gptkbp:relatedPatent |
gptkb:Mayo_Collaborative_Services_v._Prometheus_Laboratories
gptkb:Association_for_Molecular_Pathology_v._Myriad_Genetics patentable subject matter |
| gptkbp:relatedTo |
gptkb:Bilski_v._Kappos
|
| gptkbp:respondsTo |
gptkb:David_Kappos
|
| gptkbp:significance |
impact on patent law
|